A stable IgG-like bispecific antibody targeting the epidermal growth factor receptor and the type I insulin-like growth factor receptor demonstrates superior anti-tumor activity

Por Dong, Jianying, Sereno, Arlene, Aivazian, Dikran, Langley, Emma, Miller, Brian R, Snyder, William B, Chan, Eric, Cantele, Matt, Morena, Ronald, Joseph, Ingrid BJK, Boccia, Antonio, Virata, Cyrus, Gamez, James, Yco, Grace, Favis, Michael, Wu, Xiufeng, Graff, Christilyn P, Wang, Qin, Rohde, Ellen, Rennard, Rachel, Berquist, Lisa, Huang, Flora, Zhang, Ying, Gao, Sharon X, Ho, Steffan N, Demarest, Stephen J, Reff, Mitchell E, Hariharan, Kandasamy, Glaser, Scott M
Publicado em 2011